Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2015

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #2416

    Tror det gik på den immunmodulerende effekt - glæder mig til det hele, men kursmæssigt er det måske vigtigst med de korte briller at Dara-Rev-Dex kombien viser overbevisende CR

    1 Reply Last reply
    0
    • D Offline
      D Offline
      dohk
      wrote on sidst redigeret af
      #2417

      Link Preview Image
      FDA approves new Bristol-Myers treatment for multiple myeloma

      The U.S. Food and Drug Administration said on Monday it had approved a drug to be sold by Bristol-Myers Squibb Co as a treatment for a form of blood cancer. The FDA said it approved the treatment, Empliciti, to be used in multiple myeloma patients in combination with Celgene Corp's Revlimid and common anti-inflammatory drug dexamethasone. The National Cancer Institute estimates there will be 26,850 new cases of multiple myeloma and 11,240 related deaths in the United States in 2015.

      favicon

      Yahoo Finance (finance.yahoo.com)

      1 Reply Last reply
      0
      • D Offline
        D Offline
        dohk
        wrote on sidst redigeret af
        #2418

        Så kom emplicit godkendelsen.

        1 Reply Last reply
        0
        • J Offline
          J Offline
          Jedi
          wrote on sidst redigeret af
          #2419

          PFS 19.4 mdr med Elo-Len-Dex (14.9 mdr med Len-Dex alene) - det er den PFS Dara-Len-Dex gerne skal slå i Pollux studiet. Kan vi få en indikation af PFS fra Dara-Len-Dex fase 2 kombi studiet på ASH?

          1 Reply Last reply
          0
          • J Offline
            J Offline
            Jedi
            wrote on sidst redigeret af
            #2420

            Access to this page has been denied

            px-captcha

            favicon

            (seekingalpha.com)

            1 Reply Last reply
            0
            • M Offline
              M Offline
              Mcjean
              wrote on sidst redigeret af
              #2421

              http://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=5fb5cd59-0024-471a-b561-b3eff2b89715 31 aug. 59.322.130 stk - nu 209.133 stk's flere aktier. Nogen der kan

              1 Reply Last reply
              0
              • M Offline
                M Offline
                Mcjean
                wrote on sidst redigeret af
                #2422

                se udnyttelsesgraden og sige et eller andet begavet om det?

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #2423

                  Hvorfor er der to dara/len(rev)
                  /dex studier - Gen503 og Pollux?

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #2424

                    Har nu mere ondt af Marshall Wace 😉

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #2425

                      Gen503 var jo et fase 1/2 dose escalation study, dar var baggrunden for Pollux.

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #2426

                        Jamen Gen503 er jo det
                        der kommer på ASH nu

                        1 Reply Last reply
                        0
                        • Legolas23L Offline
                          Legolas23L Offline
                          Legolas23
                          wrote on sidst redigeret af
                          #2427

                          Kommer der nyt fra både Castor og Pollux ?

                          1 Reply Last reply
                          0
                          • BudweisB Offline
                            BudweisB Offline
                            Budweis
                            wrote on sidst redigeret af
                            #2428

                            Fra dagens Deutche analyse af pharma og biotek sektoren i EU - "In our view Actelion, Genmab and SOBI are the most likely takeout targets as they have strong recently approved potential blockbuster products and better shareholder structure"

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #2429

                              🙂 Let it come

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #2430

                                Tak Budweis. 🙂

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #2431

                                  Over 100 sider fra Deutsche !

                                  1 Reply Last reply
                                  0
                                  • BudweisB Offline
                                    BudweisB Offline
                                    Budweis
                                    wrote on sidst redigeret af
                                    #2432

                                    nemlig - det er en solid rapport

                                    1 Reply Last reply
                                    0
                                    • Legolas23L Offline
                                      Legolas23L Offline
                                      Legolas23
                                      wrote on sidst redigeret af
                                      #2433

                                      Dissekerer de pipelinen op i kurspoint ? Det kunne være interessant at høre, hvor meget de enkelte produkter er normeret til ?

                                      1 Reply Last reply
                                      0
                                      • BudweisB Offline
                                        BudweisB Offline
                                        Budweis
                                        wrote on sidst redigeret af
                                        #2434

                                        nope

                                        1 Reply Last reply
                                        0
                                        • BudweisB Offline
                                          BudweisB Offline
                                          Budweis
                                          wrote on sidst redigeret af
                                          #2435

                                          genmab analysen er på tre sider

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger